Pharmacies Bring Pfizer-Wyeth Merger Suit To High Court

Law360, Washington (October 28, 2011, 5:06 PM EDT) -- A group of pharmacies asked the U.S. Supreme Court earlier this month to revive their suit alleging the $68 billion merger of Pfizer Inc. and Wyeth in 2009 raised prices and hurt competition in the pharmaceutical market.

“The lower courts fundamentally misconstrued the law for defining markets, analyzing the wrong product, describing the wrong 'purpose' and ultimately reaching the wrong conclusion,” the pharmacies said in an Oct. 10 petition for writ of certiorari made public Friday.

Seven plaintiffs, including Golden Gate Pharmacy Services Inc., Marin Apothecaries...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.